30.09.2016 – The 8th International Biotechnology Meeting, hosted at the BEC Barakaldo (Bilbao), coincided with European Biotech Week

 In notas de prensa

Investors from 11 countries study 30 Spanish biotechnology projects

  • 46 investors have attended the eigth edition of Biospain, including Edmond de Rothschild Investment Partners, Forbion, Johnson & Johnson Innovation, Novartis Venture Fund, Ysios Capital Partners, Caixa Capital Risc and Cross Road Biotech
  • Biospain 2016 further consolidates its position as the fifth biggest event for business meetings, with 2,970 one-to-one meetings taking place
  • The event was attended by 1,750 individuals and 701 entities from 29 countries, meaning there was an international presence of 28%
  • 233 exhibitors came together for the event, with more exhibition space than at the previous edition
  • 84.81% of survey respondents claimed to have identified real business opportunities
Read the full press release about BIOSPAIN 2016 here: ndp_conclusiones_biospain_2016_english
Recent Posts

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here, or follow this link for more information about cookies.

Aviso de cookies